Page last updated: 2024-10-28

beta-thujaplicin and Adenocarcinoma of Lung

beta-thujaplicin has been researched along with Adenocarcinoma of Lung in 1 studies

beta-thujaplicin: structure
beta-thujaplicin : A monoterpenoid that is cyclohepta-2,4,6-trien-1-one substituted by a hydroxy group at position 2 and an isopropyl group at position 4. Isolated from Thuja plicata and Chamaecyparis obtusa, it exhibits antimicrobial activities.

Adenocarcinoma of Lung: A carcinoma originating in the lung and the most common lung cancer type in never-smokers. Malignant cells exhibit distinct features such as glandular epithelial, or tubular morphology. Mutations in KRAS, EGFR, BRAF, and ERBB2 genes are associated with this cancer.

Research

Studies (1)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's0 (0.00)18.2507
2000's0 (0.00)29.6817
2010's1 (100.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
Li, LH1
Wu, P1
Lee, JY1
Li, PR1
Hsieh, WY1
Ho, CC1
Ho, CL1
Chen, WJ1
Wang, CC1
Yen, MY1
Yang, SM1
Chen, HW1

Other Studies

1 other study available for beta-thujaplicin and Adenocarcinoma of Lung

ArticleYear
Hinokitiol induces DNA damage and autophagy followed by cell cycle arrest and senescence in gefitinib-resistant lung adenocarcinoma cells.
    PloS one, 2014, Volume: 9, Issue:8

    Topics: Acridine Orange; Adenocarcinoma; Adenocarcinoma of Lung; Annexin A5; Antineoplastic Agents, Phytogen

2014